+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report



Ursodeoxycholic acid therapy in recurrent or acquired genotype II hepatitis C virus infection after liver transplantation: a three-case report



Transplantation Proceedings 28(3): 1701-1703




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 034144915

Download citation: RISBibTeXText

PMID: 8658847


Related references

Intractable recurrent hepatitis A virus infection requiring repeated liver transplantation: a case report. Transplantation Proceedings 42(10): 4658-4660, 2011

Recurrent and acquired hepatitis C virus infection in patients after liver transplantation. Zeitschrift für Gastroenterologie 31(2): 161-162, 1993

Combination therapy with silibinin, pegylated interferon and ribavirin in a patient with hepatitis C virus genotype 3 reinfection after liver transplantation: a case report. Journal of Medical Case Reports 8(): 257-257, 2015

Simeprevir and sofosbuvir with or without ribavirin to treat recurrent genotype 1 hepatitis C virus infection after orthotopic liver transplantation. Liver Transplantation 22(5): 635-643, 2016

Achievement of sustained viral response after switching treatment from pegylated interferon α-2b to α-2a and ribavirin in patients with recurrence of hepatitis C virus genotype 1 infection after liver transplantation: a case report. Intervirology 55(4): 306-310, 2012

Famciclovir therapy for recurrent hepatitis B virus infection after liver transplantation. Transplant International 9 Suppl 1: S210-S212, 1996

Interferon alfa-2b therapy for recurrent hepatitis B virus infection following liver transplantation. Hepatology 20(4 PART 2): 139A, 1994

A pilot study of ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation 61(10): 1483-1488, 1996

Eradication of hepatitis C virus genotype 1 after liver transplantation by interferon therapy before surgery Report of three patients with analysis of interleukin-28 polymorphism, hepatitis C virus core region and interferon-sensitivity determining regio. 2011

Combination of interferon-alpha and ribavirin therapy for recurrent hepatitis C virus infection after liver transplantation. Transplantation Proceedings 32(4): 714-716, 2000

Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report. Osaka City Medical Journal 60(2): 95-100, 2015

Relations between phylogenetically-defined strains of hepatitis C virus genotype 1b and severity of recurrent hepatitis after liver transplantation. Hepatology 28(4 PART 2): 463A, 1998

Influence of antiviral therapy in the long-term outcome of recurrent hepatitis C virus infection following liver transplantation. Transplant Infectious Disease 15(4): 405-415, 2014

Therapeutic effect of adefovir dipivoxil on recurrent or de novo infection of hepatitis B virus after liver transplantation: a preliminary report. Korean Journal of Gastroenterology 45(3): 174-180, 2005